AKT1 and neoplasm: The PI3K (phosphoinositide 3-kinase)–Akt (protein kinase B) signalling pathway is frequently activated in tumour cells, often via loss of the tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10), but also via activating mutations in subunits of PI3K or upstream receptors [26].